Drug Profile
Research programme: casein kinase II inhibitors - Jasco Pharmaceuticals
Alternative Names: Casein kinase II alpha subunit inhibitors; CK2α inhibitorsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Jasco Pharmaceuticals
- Class Small molecules
- Mechanism of Action Casein kinase II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in USA